Literature DB >> 15468347

The evolving use of tumor necrosis factor inhibitors in rheumatoid arthritis.

Arthur Kavanaugh, Stanley Cohen, John J Cush.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15468347

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  13 in total

1.  Racial and ethnic disparities in disease activity and function among persons with rheumatoid arthritis from university-affiliated clinics.

Authors:  J L Barton; L Trupin; D Schillinger; S A Gansky; C Tonner; M Margaretten; V Chernitskiy; J Graf; J Imboden; E Yelin
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-09       Impact factor: 4.794

2.  The case of tumour necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis: a budget impact analysis.

Authors:  Jan Sørensen; Lis S Andersen
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  Health economics: implications for novel antirheumatic therapies.

Authors:  A Kavanaugh
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

4.  [Health economic aspects of a stratified medicine for rheumatoid arthritis].

Authors:  M Frank; T Mittendorf
Journal:  Z Rheumatol       Date:  2013-02       Impact factor: 1.372

5.  Psoriatic arthritis: pathogenesis and novel immunomodulatory approaches to treatment.

Authors:  Sarah Cassell; Arthur Kavanaugh
Journal:  J Immune Based Ther Vaccines       Date:  2005-09-02

6.  Patients' and rheumatologists' preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain.

Authors:  Joan M Nolla; Manuel Rodríguez; Emilio Martin-Mola; Enrique Raya; Isabel Ibero; Gonzalo Nocea; Belén Aragon; Luis Lizán; Miriam Prades
Journal:  Patient Prefer Adherence       Date:  2016-06-20       Impact factor: 2.711

7.  Patient preferences and satisfaction in the treatment of rheumatoid arthritis with biologic therapy.

Authors:  Jennifer L Barton
Journal:  Patient Prefer Adherence       Date:  2009-11-29       Impact factor: 2.711

8.  Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication--"It could give me two heads and I'd still try it!".

Authors:  Paul Arkell; Sarah Ryan; Ann Brownfield; Anthony Cadwgan; Jon Packham
Journal:  BMC Musculoskelet Disord       Date:  2013-05-10       Impact factor: 2.362

9.  Interleukin-6 inhibitors in the treatment of rheumatoid arthritis.

Authors:  Stephanie Hennigan; Arthur Kavanaugh
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423

10.  Anti-arthritic potential of the plant Justicia gendarussa Burm F.

Authors:  Jaijesh Paval; Srinivasan Keloth Kaitheri; Bhagath Kumar Potu; Sreejith Govindan; Raju Suresh Kumar; Sareesh Naduvil Narayanan; Sudheer Moorkoth
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.